Traws Pharma, Inc. (TRAW)
0.416
-0.03
(-6.56%)
USD |
NASDAQ |
Oct 12, 16:00
0.42
0.00 (0.00%)
After-Hours: 06:26
Traws Pharma Shareholders Equity (Quarterly) : 1.691M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.691M |
| March 31, 2026 | -5.311M |
| December 31, 2025 | -0.629M |
| September 30, 2025 | 4.545M |
| June 30, 2025 | 8.262M |
| March 31, 2025 | 6.00M |
| December 31, 2024 | -31.63M |
| September 30, 2024 | -2.033M |
| June 30, 2024 | 6.099M |
| March 31, 2024 | 6.015M |
| December 31, 2023 | 10.67M |
| September 30, 2023 | 14.52M |
| June 30, 2023 | 18.90M |
| March 31, 2023 | 22.88M |
| December 31, 2022 | 28.31M |
| September 30, 2022 | 33.37M |
| June 30, 2022 | 38.48M |
| March 31, 2022 | 42.29M |
| December 31, 2021 | 46.12M |
| September 30, 2021 | 49.67M |
| June 30, 2021 | 32.99M |
| March 31, 2021 | 37.15M |
| December 31, 2020 | 6.175M |
| September 30, 2020 | 12.22M |
| June 30, 2020 | 15.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 21.35M |
| December 31, 2019 | 11.57M |
| September 30, 2019 | -6.041M |
| June 30, 2019 | -4.546M |
| March 31, 2019 | -1.536M |
| December 31, 2018 | 5.387M |
| September 30, 2018 | 10.86M |
| June 30, 2018 | 15.92M |
| March 31, 2018 | -7.705M |
| December 31, 2017 | -11.69M |
| September 30, 2017 | -6.908M |
| June 30, 2017 | -0.388M |
| March 31, 2017 | -3.541M |
| December 31, 2016 | 4.297M |
| September 30, 2016 | 9.185M |
| June 30, 2016 | 1.217M |
| March 31, 2016 | 5.989M |
| December 31, 2015 | 10.01M |
| September 30, 2015 | 3.368M |
| June 30, 2015 | 3.745M |
| March 31, 2015 | 11.76M |
| December 31, 2014 | 22.75M |
| September 30, 2014 | 35.27M |
| June 30, 2014 | 48.52M |
| March 31, 2014 | 63.91M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.47M |
| Total Liabilities (Quarterly) | 9.779M |
| Current Ratio | 0.9269 |